Common gene pathways and families altered by DNA methylation in breast and prostate cancers

被引:19
作者
Day, Tanya K. [1 ]
Bianco-Miotto, Tina [2 ,3 ]
机构
[1] Univ Adelaide, Dame Roma Mitchell Canc Res Labs, Discipline Med, Hanson Inst,Adelaide Prostate Canc Res Ctr, Adelaide, SA 5064, Australia
[2] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Inst, Adelaide, SA 5064, Australia
[3] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA 5064, Australia
关键词
breast; prostate; biomarker; gene regulation; neoplasia; CPG ISLAND MICROARRAYS; CELL-LINES; EPIGENETIC ALTERATIONS; PROFILING REVEALS; RECEPTOR STATUS; GENOME; EXPRESSION; IDENTIFICATION; CHROMATIN; RISK;
D O I
10.1530/ERC-13-0204
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetic modifications, such as DNA methylation, are widely studied in cancer as they are stable and easy to measure genome wide. DNA methylation changes have been used to differentiate benign from malignant tissue and to predict tumor recurrence or patient outcome. Multiple genome wide DNA methylation studies in breast and prostate cancers have identified genes that are differentially methylated in malignant tissue compared with non-malignant tissue or in association with hormone receptor status or tumor recurrence. Although this has identified potential biomarkers for diagnosis and prognosis, what is highlighted by reviewing these studies is the similarities between breast and prostate cancers. In particular, the gene families/pathways targeted by DNA methylation in breast and prostate cancers have significant overlap and include homeobox genes, zinc finger transcription factors, S100 calcium binding proteins, and potassium voltage-gated family members. Many of the gene pathways targeted by aberrant methylation in breast and prostate cancers are not targeted in other cancers, suggesting that some of these targets may be specific to hormonal cancers. Genome wide DNA methylation profiles in breast and prostate cancers will not only define more specific and sensitive biomarkers for cancer diagnosis and prognosis but also identify novel therapeutic targets, which may be direct targets of agents that reverse DNA methylation or which may target novel gene families that are themselves DNA methylation targets.
引用
收藏
页码:R215 / R232
页数:18
相关论文
共 65 条
[1]   Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? [J].
Baylin, SB ;
Ohm, JE .
NATURE REVIEWS CANCER, 2006, 6 (02) :107-116
[2]   A decade of exploring the cancer epigenome - biological and translational implications [J].
Baylin, Stephen B. ;
Jones, Peter A. .
NATURE REVIEWS CANCER, 2011, 11 (10) :726-734
[3]   Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy [J].
Cai, Changmeng ;
Balk, Steven P. .
ENDOCRINE-RELATED CANCER, 2011, 18 (05) :R175-R182
[4]  
Chan MF, 2000, CURR TOP MICROBIOL, V249, P75
[5]   SIGMA: A system for integrative genomic microarray analysis of cancer genomes [J].
Chari, Raj ;
Lockwood, William W. ;
Coe, Bradley P. ;
Chu, Anna ;
Macey, Devon ;
Thomson, Andrew ;
Davies, Jonathan J. ;
MacAulay, Calum ;
Lam, Wan L. .
BMC GENOMICS, 2006, 7 (1)
[6]   An integrative multi-dimensional genetic and epigenetic strategy to identify aberrant genes and pathways in cancer [J].
Chari, Raj ;
Coe, Bradley P. ;
Vucic, Emily A. ;
Lockwood, William W. ;
Lam, Wan L. .
BMC SYSTEMS BIOLOGY, 2010, 4
[7]   Epigenetic biomarkers in prostate cancer: Current and future uses [J].
Chiam, Karen ;
Ricciardelli, Carmela ;
Bianco-Miotto, Tina .
CANCER LETTERS, 2014, 342 (02) :248-256
[8]   Epigenetic regulation of prostate cancer [J].
Chin, Suyin P. ;
Dickinson, Joanne L. ;
Holloway, Adele F. .
CLINICAL EPIGENETICS, 2011, 2 :151-169
[9]   Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling [J].
Chung, Woonbok ;
Kwabi-Addo, Bernard ;
Ittmann, Michael ;
Jelinek, Jaroslav ;
Shen, Lanlan ;
Yu, Yinhua ;
Issa, Jean-Pierre J. .
PLOS ONE, 2008, 3 (04)
[10]   Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity [J].
Coolen, Marcel W. ;
Stirzaker, Clare ;
Song, Jenny Z. ;
Statham, Aaron L. ;
Kassir, Zena ;
Moreno, Carlos S. ;
Young, Andrew N. ;
Varma, Vijay ;
Speed, Terence P. ;
Cowley, Mark ;
Lacaze, Paul ;
Kaplan, Warren ;
Robinson, Mark D. ;
Clark, Susan J. .
NATURE CELL BIOLOGY, 2010, 12 (03) :235-U37